SC
Strom Carrie C VP Senior
OFFICER F
Insider track record Executive Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Strom Carrie C, VP Senior. Director active across 1 company, notably AbbVie Inc.. Aggregated, 25 filings have been recorded. Split: 0 buy · 7 sells. Total volume traded: €4.6m. History available since 3 May 2021. The latest transaction was disclosed on 11 May 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Strom Carrie C Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 25 total
● SVP & PRES GLOBAL ALLERG AESTH · Executives · 11 May 2023 · AbbVie Inc. 2,876 shares @ US$146.42 3.3% of flow Common Stock, $0.01 par value SEC:0001415889-23-007908:0
● SVP & PRES GLOBAL ALLERG AESTH · Executives · 5 Mar 2023 · AbbVie Inc. 449 shares @ US$156.06 0.6% of flow Common Stock, $0.01 par value SEC:0001415889-23-004428:0
● SVP & PRES GLOBAL ALLERG AESTH · Executives · 28 Feb 2023 · AbbVie Inc. 5,762 shares @ US$154.28 7.1% of flow Common Stock, $0.01 par value SEC:0001415889-23-003857:0
◇ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 7,809 shares @ US$56.93 3.5% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:2
◇ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 6,370 shares @ US$67.25 3.4% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:3
▼ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 5,615 shares @ US$150.71 6.7% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:4
▼ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 7,780 shares @ US$151.28 9.4% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:5
▼ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 6,533 shares @ US$150.74 7.9% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:6
▼ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 7,646 shares @ US$151.29 9.2% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:7
▼ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 567 shares @ US$150.78 0.7% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:8
▼ SVP & PRES GLOBAL ALLERG AESTH · Executives · 21 Feb 2023 · AbbVie Inc. 400 shares @ US$151.34 0.5% of flow Common Stock, $0.01 par value SEC:0001415889-23-002946:9
◆ SVP & PRES GLOBAL ALLERG AESTH · Executives · 16 Feb 2023 · AbbVie Inc. 6,546 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002946:0
◆ SVP & PRES GLOBAL ALLERG AESTH · Executives · 16 Feb 2023 · AbbVie Inc. 5,074 shares 0Common Stock, $0.01 par value SEC:0001415889-23-002946:1
● SVP & Pres Global Allerg Aesth · Executives · 11 May 2022 · AbbVie Inc. 2,876 shares @ US$152.09 0.0001% mcap 7.4% of flow Common Stock, $0.01 par value SEC:0001179110-22-003023:0
● SVP & Pres Global Allerg Aesth · Executives · 7 May 2022 · AbbVie Inc. 234 shares @ US$152.83 0.0000% mcap 0.6% of flow Common Stock, $0.01 par value SEC:0001179110-22-002934:0
● SVP & Pres Global Allerg Aesth · Executives · 5 Mar 2022 · AbbVie Inc. 448 shares @ US$150.56 0.0000% mcap 1.1% of flow Common Stock, $0.01 par value SEC:0001179110-22-002018:0
● SVP & Pres Global Allerg Aesth · Executives · 2 Mar 2022 · AbbVie Inc. 810 shares @ US$147.69 0.0000% mcap 1.9% of flow Common Stock, $0.01 par value SEC:0001179110-22-001925:0
● SVP & Pres Global Allerg Aesth · Executives · 25 Feb 2022 · AbbVie Inc. 2,840 shares @ US$149.54 0.0001% mcap 6.8% of flow Common Stock, $0.01 par value SEC:0001179110-22-001842:0
◆ SVP & Pres Global Allerg Aesth · Executives · 17 Feb 2022 · AbbVie Inc. 5,727 shares 0Common Stock, $0.01 par value SEC:0001179110-22-001520:0
◆ SVP & Pres Global Allerg Aesth · Executives · 7 Feb 2022 · AbbVie Inc. 4,184 shares @ US$47.27 0.0000% mcap 3.1% of flow Common Stock, $0.01 par value SEC:0001179110-22-000922:0
● SVP & Pres Global Allerg Aesth · Executives · 31 Dec 2021 · AbbVie Inc. 10,336 shares @ US$135.93 0.0003% mcap 22.2% of flow Common Stock, $0.01 par value SEC:0001179110-22-000262:0
▼ SVP & Pres Global Allerg Aesth · Executives · 23 Aug 2021 · AbbVie Inc. 5,057 shares @ US$120.00 5.4% of flow Common Stock, $0.01 par value SEC:0001179110-21-008422:0
● SVP & Pres Global Allerg Aesth · Executives · 11 May 2021 · AbbVie Inc. 2,887 shares @ US$116.22 2.9% of flow Common Stock, $0.01 par value SEC:0001179110-21-005245:0
● SVP & Pres Global Allerg Aesth · Executives · 7 May 2021 · AbbVie Inc. 234 shares @ US$116.08 0.2% of flow Common Stock, $0.01 par value SEC:0001179110-21-005196:0
◇ SVP & Pres Global Allerg Aesth · Executives · 3 May 2021 · AbbVie Inc. 4,184 shares @ US$41.39 1.5% of flow Common Stock, $0.01 par value SEC:0001179110-21-004898:0
About Strom Carrie C Strom Carrie C is VP Senior and SVP & PRES GLOBAL ALLERG AESTH at AbbVie Inc. They have 25 filings in total. Across the 25 sampled recent filings, sales amount to EUR 4552013, no purchases are indicated, and the period runs from 2021-05-05 to 2023-05-12. The most frequent transaction nature is Retenue fiscale.